Written By: Suhani Pattnaik Entertainment industry being home to many artistic skills and creative works can be a huge legal minefield. An iota of carelessness can jeopardize the w…

Being a celebrity is really worth of having everything. But does this everything allows you to monopolize your name as a trademark, which will have the effect to secluding others f…

Written By: Rosalin Dhal Historic Recurrence is a Natural Phenomenon. When Supreme Court cancelled Novartis’ Patent on Glivec, it was clearly a tragedy for the latter and was expec…

The recent judgment delivered by the Delhi State Consumer Forum against woodland is an eye opener for entities operating in single brand retail. In a short judgment, the forum repr…

Written By: Avasi Mohanty Bollywood is widely known to be the breeding ground for Masala. Most of this “Masala” is not only limited to gossip, disputes and patch-ups, but also to s…

In a big setback to the Indian Generic Drug-makers, Delhi High Court has allowed the writ petition filed by Gilead Pharmasset LLC against the Union of India for an adverse order pa…

Being patriotic is one thing and being affectionate about something is different. But in the garb of your patriotism, you can’t just go to the extent of seeking exclusivity over yo…

Written by: Swasti Panda The recent outrage against Rajkumar Hirani’s masterpiece ‘PK’ for hurting religious sentiments was struck down as groundless by the Delhi High Court. But j…

Written By: Lipsa Dash The recent outrageous news about leakage of several private pictures of Jennifer Lawrence, the Oscar winning actress, popular for being the lead star in Holl…

The Curious Case of Sorafenib tosylate, as I had put it earlier, has finally reached its climax. In an order passed on 12 December 2014, the Supreme Court of India has declined to…

For Indians, the term ‘Khadi’ has a patriotic notion attached to it that finds its roots in the Swadeshi movement spearheaded by Mahatma Gandhi during India’s Freedom Struggle way…

The Ghost of FDA continues to haunt Ranbaxy. After blacklisting all of its Indian facilities, the FDA (US Federal Drug Administration) has now annulled its tentative approval to gr…